As of August 04, 2026, Biovie's top three insider holders are Jonathan M Adams (Evp Liver Cirrhosis Programs, 48.63K shares), Penelope Markham (Evp Liver Cirrhosis Rd, 47.84K shares), Joanne Wendy Kim (Chief Financial Officer, 44.15K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Richard J Berman | - | 40,643 | 0 | 07 Jan, 2025 |
| Sigmund Rogich | - | 36,926 | 0 | 07 Jan, 2025 |
| Christopher Reading | Evp Neuroscience Rd | 37,148 | 0 | 22 Feb, 2023 |
| Robert J Hariri | - | 42,254 | 0 | 05 Dec, 2023 |
| Jonathan M Adams | Evp Liver Cirrhosis Programs | 48,630 | 0 | 15 Feb, 2022 |
| Penelope Markham | Evp Liver Cirrhosis Rd | 47,841 | 0 | 22 Feb, 2023 |
| Joanne Wendy Kim | Chief Financial Officer | 44,148 | 0 | 13 Dec, 2023 |
| Clarence N. Ahlem | Evp Neuroscience Product Dev. | 37,148 | 0 | 21 Feb, 2023 |
| Joseph M Palumbo | Chief Medical Officer | 37,148 | 0 | 22 Feb, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 05 Jan, 2026 | Amy Suzon Chappell | Stock Option (right to buy) | A | 57,500 | $0.00 | 57,500 | D | A |
| 05 Jan, 2026 | Kameel D. Farag | Stock Option (right to buy) | A | 57,500 | $0.00 | 57,500 | D | A |
| 05 Jan, 2026 | Sigmund Rogich | Stock Option (right to buy) | A | 70,000 | $0.00 | 70,000 | D | A |
| 05 Jan, 2026 | Joanne Wendy Kim | Stock Option (right to buy) | A | 110,100 | $0.00 | 110,100 | D | A |
| 05 Jan, 2026 | Michael Edward Sherman | Stock Option (right to buy) | A | 80,000 | $0.00 | 80,000 | D | A |
| 05 Jan, 2026 | Joseph M Palumbo | Stock Option (right to buy) | A | 132,000 | $0.00 | 132,000 | D | A |
| 05 Jan, 2026 | Joseph M Palumbo | Stock Option (right to buy) | A | 132,000 | $0.00 | 132,000 | D | A |
| 05 Jan, 2026 | Joanne Wendy Kim | Stock Option (right to buy) | A | 110,100 | $0.00 | 110,100 | D | A |
| 05 Jan, 2026 | Amy Suzon Chappell | Stock Option (right to buy) | A | 57,500 | $0.00 | 57,500 | D | A |
| 05 Jan, 2026 | Kameel D. Farag | Stock Option (right to buy) | A | 57,500 | $0.00 | 57,500 | D | A |
| 05 Jan, 2026 | Sigmund Rogich | Stock Option (right to buy) | A | 70,000 | $0.00 | 70,000 | D | A |
| 05 Jan, 2026 | Kameel D. Farag | Stock Option (right to buy) | A | 57,500 | $0.00 | 57,500 | D | A |
| 05 Jan, 2026 | Joanne Wendy Kim | Stock Option (right to buy) | A | 110,100 | $0.00 | 110,100 | D | A |
| 05 Jan, 2026 | Sigmund Rogich | Stock Option (right to buy) | A | 70,000 | $0.00 | 70,000 | D | A |
| 05 Jan, 2026 | Joseph M Palumbo | Stock Option (right to buy) | A | 132,000 | $0.00 | 132,000 | D | A |
| 05 Jan, 2026 | Michael Edward Sherman | Stock Option (right to buy) | A | 80,000 | $0.00 | 80,000 | D | A |
| 05 Jan, 2026 | Amy Suzon Chappell | Stock Option (right to buy) | A | 57,500 | $0.00 | 57,500 | D | A |
| 05 Jan, 2026 | Michael Edward Sherman | Stock Option (right to buy) | A | 80,000 | $0.00 | 80,000 | D | A |
| 05 Jan, 2026 | Michael Edward Sherman | Stock Option (right to buy) | A | 341,100 | $0.00 | 341,100 | D | A |
| 05 Jan, 2026 | Michael Edward Sherman | Stock Option (right to buy) | A | 341,100 | $0.00 | 341,100 | D | A |